Simpson Thacher represented Unilabs SubHolding AB (publ), a wholly owned subsidiary of Unilabs Holding AB (“Unilabs”), an Apax portfolio company, in connection with a Rule 144A and Regulation S offering of €250 million in aggregate principal amount of its 5.75% Senior Notes due 2025. The transaction closed on May 5, 2017. Unilabs used the net proceeds from this offering to (i) provide a portion of the permanent financing for its recently completed acquisition of Alpha Medical, a leading laboratory diagnostics provider serving customers in Slovakia and the Czech Republic, and (ii) repay in full €125 million in aggregate principal amount of second lien PIK toggle notes due 2022 issued by Unilabs MidHolding AB (publ), the direct parent of Unilabs SubHolding AB (publ).

Unilabs is one of Europe’s leading suppliers of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies and the general public.

The Simpson Thacher team included Nick Shaw, Carol Daniel, Noam Katz, Martin Weatherston-Wilson, Pelin Demirdere Eski and Donovan Westbrook (Capital Markets); Ian Barratt, Kate Sinclair and Jason Lim (Credit); and Robert Holo, Jasmine Hay and John Torrenti (Tax).